Glutaminsyre-decarboxylase-antistoffer og diabetes.
Research output: Contribution to journal › Journal article › Research › peer-review
The 1999 WHO classification delineates immune mediated type 1 diabetes from other types of diabetes by the presence of auto-antibodies against beta-cell constituents. The GAD65 auto-antibody test is the method of first choice because it has the highest sensitivity, specificity and positive predictive value and is the most standardized and well-characterized type 1 diabetes related auto-antibody analysis. It is recommended that demonstration of GAD auto-antibodies leads to diagnosis, classification or re-classification of diabetes patients as immune mediated type 1 diabetes.
Udgivelsesdato: 2007-Jan-22
Udgivelsesdato: 2007-Jan-22
| Translated title of the contribution | Auto-antibodies against glutamic acid decarboxylase and diabetes |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for læger |
| Volume | 169 |
| Issue number | 4 |
| Pages (from-to) | 300-4 |
| Number of pages | 4 |
| ISSN | 0041-5782 |
| Publication status | Published - 2007 |
Bibliographical note
Keywords: Autoantibodies; Autoantigens; Decision Making; Diabetes Mellitus, Type 1; Glutamate Decarboxylase; Humans; Insulin-Secreting Cells; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity
ID: 8465646